SE8900067D0 - New thrombolytic compositions - Google Patents

New thrombolytic compositions

Info

Publication number
SE8900067D0
SE8900067D0 SE19898900067A SE8900067A SE8900067D0 SE 8900067 D0 SE8900067 D0 SE 8900067D0 SE 19898900067 A SE19898900067 A SE 19898900067A SE 8900067 A SE8900067 A SE 8900067A SE 8900067 D0 SE8900067 D0 SE 8900067D0
Authority
SE
Sweden
Prior art keywords
treating
new thrombolytic
thrombolytic compositions
compositions
new
Prior art date
Application number
SE19898900067A
Other languages
English (en)
Other versions
SE462829B (sv
Inventor
*Pohl G
Original Assignee
Kabigen Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabigen Ab filed Critical Kabigen Ab
Priority to SE8900067A priority Critical patent/SE462829B/sv
Publication of SE8900067D0 publication Critical patent/SE8900067D0/sv
Priority to US07/459,210 priority patent/US5202121A/en
Priority to CA002007075A priority patent/CA2007075C/en
Priority to DK90850008.5T priority patent/DK0381640T3/da
Priority to AT90850008T priority patent/ATE80308T1/de
Priority to EP90850008A priority patent/EP0381640B1/en
Priority to ES90850008T priority patent/ES2044534T3/es
Priority to DE9090850008T priority patent/DE69000290T2/de
Priority to AU47768/90A priority patent/AU624466B2/en
Priority to JP2001149A priority patent/JP2958650B2/ja
Publication of SE462829B publication Critical patent/SE462829B/sv
Priority to GR920402378T priority patent/GR3006053T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A61K38/166—Streptokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8900067A 1989-01-10 1989-01-10 Trombolytiskt aktiva kompositioner innehaallande en modifierad plasminogenaktivator av vaevnadstyp samt en normal human t-pa, streptokinas eller humant urokinas SE462829B (sv)

Priority Applications (11)

Application Number Priority Date Filing Date Title
SE8900067A SE462829B (sv) 1989-01-10 1989-01-10 Trombolytiskt aktiva kompositioner innehaallande en modifierad plasminogenaktivator av vaevnadstyp samt en normal human t-pa, streptokinas eller humant urokinas
US07/459,210 US5202121A (en) 1989-01-10 1989-12-29 Thrombolytic compositions
CA002007075A CA2007075C (en) 1989-01-10 1990-01-03 New thrombolytic compositions
AU47768/90A AU624466B2 (en) 1989-01-10 1990-01-08 New thrombolytic compositions
AT90850008T ATE80308T1 (de) 1989-01-10 1990-01-08 Thrombotische zusammensetzungen.
DK90850008.5T DK0381640T3 (da) 1989-01-10 1990-01-08 Thrombolytiske præparater
EP90850008A EP0381640B1 (en) 1989-01-10 1990-01-08 New thrombolytic compositions
ES90850008T ES2044534T3 (es) 1989-01-10 1990-01-08 Un metodo para la preparacion de una composicion tromboliticamente activa.
DE9090850008T DE69000290T2 (de) 1989-01-10 1990-01-08 Thrombotische zusammensetzungen.
JP2001149A JP2958650B2 (ja) 1989-01-10 1990-01-09 新規な血栓溶解組成物
GR920402378T GR3006053T3 (sv) 1989-01-10 1992-10-22

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8900067A SE462829B (sv) 1989-01-10 1989-01-10 Trombolytiskt aktiva kompositioner innehaallande en modifierad plasminogenaktivator av vaevnadstyp samt en normal human t-pa, streptokinas eller humant urokinas

Publications (2)

Publication Number Publication Date
SE8900067D0 true SE8900067D0 (sv) 1989-01-10
SE462829B SE462829B (sv) 1990-09-10

Family

ID=20374707

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8900067A SE462829B (sv) 1989-01-10 1989-01-10 Trombolytiskt aktiva kompositioner innehaallande en modifierad plasminogenaktivator av vaevnadstyp samt en normal human t-pa, streptokinas eller humant urokinas

Country Status (11)

Country Link
US (1) US5202121A (sv)
EP (1) EP0381640B1 (sv)
JP (1) JP2958650B2 (sv)
AT (1) ATE80308T1 (sv)
AU (1) AU624466B2 (sv)
CA (1) CA2007075C (sv)
DE (1) DE69000290T2 (sv)
DK (1) DK0381640T3 (sv)
ES (1) ES2044534T3 (sv)
GR (1) GR3006053T3 (sv)
SE (1) SE462829B (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6682733B1 (en) * 1987-06-18 2004-01-27 Roche Diagnostics, Gmbh Fibrinolytic enzymes
GB8919803D0 (en) * 1989-09-01 1989-10-18 Ciba Geigy Pharmaceutical compositions
US5830468A (en) * 1995-05-17 1998-11-03 The New York Blood Center, Inc. Fibrin(ogen) degradation by fibrinolytic matrix metalloproteinase
US6020181A (en) * 1995-05-17 2000-02-01 New York Blood, Inc. Inhibition of thrombus formation by medical related apparatus comprising treating with fibrinolytic matrix metalloproteinase

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8503097A (nl) * 1985-11-11 1987-06-01 Leuven Res & Dev Vzw Geneesmiddel met thrombolytische werking.
WO1987004722A1 (en) * 1986-01-31 1987-08-13 Genetics Institute, Inc. Novel thrombolytic proteins
PT84589B (en) * 1986-04-02 1989-05-09 Beecham Group Plc Process for preparing a fibrinolytic enzyme
NL8701021A (nl) * 1987-04-29 1988-11-16 Stichting Centraal Lab Humane t-pa(u-pa) substitutie-mutant eiwitten, daarvoor coderend recombinant dna, getransfecteerde gastheercellen, bereiding van de mutant eiwitten, en farmaceutische preparaten.
US4935237A (en) * 1988-03-21 1990-06-19 Genentech, Inc. Processes for the preparation of t-PA mutants
US4963357A (en) * 1987-10-09 1990-10-16 Monsanto Company Tissue plasminogen activator modified by the substitution of Arg for Cys at position 73, methods and pharmaceutical compositions therefor
DE3741149A1 (de) * 1987-12-04 1989-06-15 Thomae Gmbh Dr K Zubereitungsformen zur verhinderung von adhaesionen von organen und organteilen

Also Published As

Publication number Publication date
DE69000290T2 (de) 1993-04-22
GR3006053T3 (sv) 1993-06-21
SE462829B (sv) 1990-09-10
EP0381640B1 (en) 1992-09-09
DK0381640T3 (da) 1992-12-21
CA2007075A1 (en) 1990-07-10
DE69000290D1 (de) 1992-10-15
JP2958650B2 (ja) 1999-10-06
ATE80308T1 (de) 1992-09-15
US5202121A (en) 1993-04-13
AU624466B2 (en) 1992-06-11
CA2007075C (en) 2002-03-19
AU4776890A (en) 1990-08-30
ES2044534T3 (es) 1994-01-01
JPH02225420A (ja) 1990-09-07
EP0381640A1 (en) 1990-08-08

Similar Documents

Publication Publication Date Title
DE60139078D1 (de) Plasminogen aktivator zur verhinderung von horn- und subepithelialeintrübung nach laser-sehkraftkorrektur-chirurgie
LU92255I2 (fr) Ocriplasmine et ses dérivés pharmaceutiquement acceptables (JETREA)
ATE239084T1 (de) Mutanten der pro-urokinase
IL80659A (en) Modified tissue plasminogen activators,their preparation and pharmaceutical compositions containing them
NO20021501L (no) Fibrinolyttisk aktivt polypeptid
SE8900067D0 (sv) New thrombolytic compositions
NO905211L (no) Fremgangsmaater og materialer for ekspresjon av human plasminogenvariant.
NO941561L (no) Bifunksjonelle urokinasevarianter med forbedrede fibrinolytiske egenskaper og trombinhemmende virkning
IL111501A0 (en) Pharmaceutical compositions comprising lys-plasminogen and tissue plasminogen activator (t-PA) for the treatment of coronary thrombosis
ES2039194T3 (es) Un metodo de preparar una composicion farmaceutica tromboliticamente activa.
AU2353688A (en) Modified tissue plasminogen activator
DE59001558D1 (de) Thrombolytisch wirkendes kombinationspraeparat.

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8900067-3

Format of ref document f/p: F

NUG Patent has lapsed